What are the "grand challenges" that need to be addressed in Pseudomonas aeruginosa research?

Pseudomonas aeruginosa is the most common strain that causes infections in humans. Around 13% of P. aeruginosa infections are multidrug-resistant (MDR-PA). Mild ... PA does appear to be an 'egg' rather than a 'chicken' in COPD, with mounting evidence of its role in exacerbations, hospitalizations, and mortality. OHSU-TD-1160: Fundamental study of the initial bacterial attachment of Pseudomonas aeruginosa, Pseudomonas putida and Escherichia coli. Ohio Sea Grant is a ... Clinical Signs. P. aeruginosa infections typically are contracted from heavily infested surfaces such as tubing or water tubs, and virtually any animal can ... Sep 7, 2000 ... We conducted an epidemiologic and molecular investigation of endemic P. aeruginosa infection among infants in a neonatal intensive care unit. Nov 29, 2023 ... Agent Characteristics Risk Group: RG-2 associated with human disease, rarely serious; preventive or therapeutic interventions often available. Mar 8, 2018 ... A common source of PVGIs is Pseudomonas aeruginosa, a ubiquitous Gram-negative, rod-shaped bacterium prevalent in natural and artificial ... Abstract. Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen and a model bacterium for studying virulence and bacterial social traits. While it ... Aug 8, 2023 ... Its predilection to cause infections among immunocompromised hosts, extreme versatility, antibiotic resistance, and a wide range of dynamic ... Pseudomonas aeruginosa infections are the predominant driver of CF lung disease, and airway isolates are frequently resistant to multiple antimicrobials ...